Archives

by in
Entry Author Date Location
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
Where’s the Can-Do Spirit in Biotech? It’s Alive, Deep Down 12/03/12 National
How To Build a Biotech Cluster That Isn’t Boston or SF 11/20/12 National
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Basic Biology: The Complex Core of Drug Discovery 05/30/12 Seattle
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
Xconomy Seattle’s Top 12 Life Sciences Stories of the Year 12/28/11 Seattle
The Immunex Impact: Some Great Memories and Photos 12/02/11 Seattle
See You Tonight at “The Immunex Impact” 12/01/11 Seattle
Some Notes on Immunex 11/29/11 Seattle
Five Lessons Immunex Taught Me 11/28/11 Seattle
My Immunex Remembrance: Getting Scooped on the Biggest Biotech Story of 2001 11/18/11 Seattle
The Old Immunex Headquarters, 51 University St., Being Reinvented Once More 11/09/11 Seattle
The Fortune Story that Saved Immunex, & More Mementos: A Photo Slide Show 11/08/11 Seattle
Dendreon Shares Tank Again, Elias Joins Gates Foundation, Seattle Children’s Gets $50M, & More Seattle-Area Life Sciences News 11/03/11 Seattle
Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1 10/19/11 Seattle
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame 10/17/11 Seattle
Patricia Beckmann, Co-Inventor of Enbrel, to Join “The Immunex Impact” Dec. 1 10/13/11 Seattle
The Immunex Impact: Join Steve Gillis, Chris Henney and Many More on Dec. 1 09/15/11 Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In 09/08/11 Seattle
Finding a Solution To Our Biotech Malaise Together 05/18/11 Seattle
Editor’s Picks: Xconomy Seattle’s Top Stories of the First Quarter 03/31/11 Seattle
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End 03/11/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers 01/25/11 Seattle
See You at the JP Morgan Healthcare Conference 01/10/11 National
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Page 1 of 4 next page »